Document text
Principal Investigator: Emily K. Moser
Organization: UNIVERSITY OF FLORIDA
Fiscal Year: 2022
Award: $108,000
Funding agency: National Institute of Allergy and Infectious Diseases
PROJECT SUMMARY/ABSTRACT
The NIH estimates that up to 23.5 million Americans suffer from autoimmune disease, driven in large part
by germinal center (GC)-derived pathologic autoantibodies. GC B cells undergo iterative rounds of somatic
hypermutation of B cell receptor (BCR) genes, and selection based on BCR-antigen affinity. The random nature
of somatic hypermutation allows emergence of autoreactive B cells, but these cells die because they have lost
antigen specificity, and fail to be selected. Without a stringent selection threshold, autoreactive B cells may
survive and become long-lived plasma cells. Regulation of surface BCR turnover is critical for faithful antigen-
driven selection. During each round of somatic hypermutation and selection, the pre-mutated BCR must be
removed and replaced with the newly-mutated BCR to ensure that the genetically encoded BCR dictates
selection. Failure to remove previous “versions” of the BCR could allow selection of a BCR that has not been
tested for antigen affinity. BCR turnover is an integral component of the current model of GC selection, yet this
has never been fully explored.
The ubiquitin ligase Itch prevents humoral autoimmunity in humans and mice, but how Itch limits antibody
production is unclear. I have recently determined that Itch functions in B cells to limit GC B cells, plasma cells,
and antibody production, aligning with its role in preventing autoimmunity. Through analysis of somatic mutations
in GC B cells, I now show that Itch supports stringent selection of GC B cells. After immunization, I identified
Itch deficient GC B cells bearing antigen-specific surface BCRs, yet containing nonproductive BCR genes.
These data support the idea that Itch prevents survival of B cells acquiring detrimental BCR mutations and
promotes pre-mutated BCR removal after mutation. Itch has been shown to regulate BCR internalization and
trafficking to lysosomes in naïve B cells. It is unknown how Itch controls BCR turnover in GCs, and how this
impacts GC selection. In this proposal I will test the hypothesis that Itch regulates surface BCR turnover in GC
B cells to ensure stringent selection and prevent the emergence of autoantibody. I will use B cell specific Itch
knockout mice and analysis of antigen-specific GC B cell somatic mutations to model GC dynamics and
determine how Itch regulates selection. Additionally, I will define the role of Itch in GC BCR removal and
replacement using cell biology approaches to probe surface BCR removal/replacement in GC B cells. To
complete these studies, I have formed collaborations with experts in immunoreceptor biology, intracellular
trafficking, next generation sequencing, and computational modeling. These studies will advance the
understanding of mechanisms regulating selection in GCs, and provide a unique system in which to study the
link between BCR turnover, GC B cell selection, and antibody responses.
Terms: <Ab response><Abscission><Affinity><American><Antibodies><Antibody Formation><Antibody Production><Antibody Response><Antigens><Autoantibodies><Autoantigens><Autoimmune Diseases><Autoimmune Status><Autoimmunity><Autologous Antigens><B blood cells><B cell><B cell receptor><B cells><B-Cell Antigen Receptor><B-Cells><B-Lymphocytes><B-cell><B-cell receptor repertoire sequencing><B-cell receptor sequencing><BCR repertoire sequencing><BCR seq><BCR sequencing><BCRseq><Binding><Biological Response Modifiers><Biology><Biomodulators><Blood Plasma Cell><Blood Serum><Cell Body><Cell Communication and Signaling><Cell Count><Cell Number><Cell Signaling><Cell Surface Receptors><Cells><Cellular biology><Collaborations><Computational Biology><Computer Models><Computerized Models><Confocal Microscopy><Data><Development><E3 Ligase><E3 Ubiquitin Ligase><Endocytosis><Ensure><Excision><Extirpation><Failure><Flow Cytofluorometries><Flow Cytofluorometry><Flow Cytometry><Flow Microfluorimetry><Flow Microfluorometry><Foundations><Future><Generations><Genetic Alteration><Genetic Change><Genetic defect><Germinal Center><Goals><Hemagglutinin><Human><Ig Somatic Hypermutation><Immune Mediators><Immune Mediators/Modulators><Immune Regulators><Immune response><Immunization><Immunize><Immunoglobulin Somatic Hypermutation><Immunologic Sensitization><Immunologic Stimulation><Immunological Sensitization><Immunological Stimulation><Immunological response><Immunostimulation><Impairment><Influenza A><Influenza A virus><Influenza Viruses Type A><Influenzavirus A><Intracellular Communication and Signaling><Itching><KO mice><Kinetics><Knock-out Mice><Knockout Mice><Label><Ligands><Link><Lysosomes><Mice><Mice Mammals><Modeling><Modern Man><Molecular><Molecular Interaction><Molecular Target><Murine><Mus><Mutate><Mutation><Mutation Analysis><NGS Method><NGS system><NIH><National Institutes of Health><Nature><Neutralization Tests><Neutralizing antibody assay><Null Mouse><Orthomyxovirus Type A><Pathologic><Pathology><Pathway interactions><Plasma Cells><Plasmacytes><Polyubiquitin B><Proteins><Proteomics><Pruritic Disorder><Pruritis><Pruritus><RNA vaccine><RNA-based vaccine><Receptor Gene><Regulation><Removal><Research><Risk><Role><Self-Antigens><Serum><Shapes><Signal Transduction><Signal Transduction Systems><Signaling><Somatic Mutation><Specificity><Structure of germinal center of lymph node><Surface><Surgical Removal><System><Techniques><Testing><Therapeutic><Training><Type A Influenza><UBB gene><UBB protein><Ubiquitin B><Ubiquitin Ligase Component Gene><Ubiquitin Ligase Gene><Ubiquitin Protein Ligase><Ubiquitin-Protein Ligase Complexes><Ubiquitin-Protein Ligase E3><United States National Institutes of Health><Variant><Variation><antibody biosynthesis><antibody neutralization test><antigen based test><antigen binding><antigen bound><antigen test><autoimmune antibody><autoimmune condition><autoimmune disorder><autoreactive B cell><autoreactive antibody><base><biological signal transduction><cell biology><computational modeling><computational models><computer based models><computer biology><computerized modeling><cross reactivity><cross-link><crosslink><deep sequencing><design><designing><developmental><flow cytophotometry><functional outcomes><genome mutation><host response><immune system response><immunogen><immunoglobulin biosynthesis><immunomodulatory biologics><immunoresponse><itch sensation><mRNA vaccine><mRNA-based vaccine><neutralizing antibody><neutralizing antibody test><new drug treatments><new drugs><new therapeutics><new therapy><next gen sequencing><next generation sequencing><next generation therapeutics><nextgen sequencing><novel drug treatments><novel drugs><novel therapeutics><novel therapy><pathway><plasmocyte><prevent><preventing><programs><receptor internalization><recruit><resection><response><risk minimization><self reactive antibody><social role><somatic hypermutation><therapeutic target><trafficking><ubiquitin ligase><ubiquitin-protein ligase>